Abiraterone Tablets
Abiraterone
250mg
Abiraterone Tablets is a oncology medication containing Abiraterone, available as 250mg tablets.
Addiction Recovery
Allergy Relief
Antibiotics
Antidepressants
Antifungals
Antiparasitics
Antivirals
Autoimmune Support
Bladder Health
Bone Health
Cholesterol Management
Diabetes Management
Digestive Health
Erectile Dysfunction
Eye Care
Hair Loss
Heart & Blood Pressure
HIV Management
Hormone Therapy
Mental Health
Neurology
Nootropics
Oncology Support
Premature Ejaculation
Respiratory Health
Skin Care
Sleep Management
Thyroid Health
Weight Management
Women's Health
1 medicine
Abiraterone blocks androgen production to treat prostate cancer that no longer responds to standard hormone therapy. It must always be taken with a corticosteroid, since skipping it can cause dangerously high blood pressure and low potassium.
Abiraterone
250mg
Abiraterone Tablets is a oncology medication containing Abiraterone, available as 250mg tablets.
Abiraterone treats metastatic castration-resistant prostate cancer, prostate cancer that has spread beyond the prostate and keeps growing despite surgical or medical castration. It is given together with ongoing androgen deprivation therapy and a corticosteroid. It does not cure the disease and is not used for early or localized prostate cancer.
Prostate cancer cells depend on androgens to grow, even after the testicles' hormone production has been blocked. Abiraterone inhibits an enzyme called CYP17, which the adrenal glands, testes, and the tumor itself need to make androgens from cholesterol. Cutting off this remaining hormone supply slows tumor growth. Blocking the same enzyme also lowers cortisol, which is why a replacement corticosteroid is required alongside treatment.
Common effects include fatigue, joint swelling or pain, high blood pressure, mild ankle swelling, low potassium, and stomach upset.
Stop and seek urgent medical care for any of these:
This page is educational and does not replace advice from a doctor or pharmacist who knows your health history.